‘I always had entrepreneurial ambitions and this was first-hand evidence of an unmet need’
Neuromod’s chief executive Dr Ross O’Neill says his company’s Lenire device, which aids tinnitus sufferers, can establish a sizeable market — particularly in the US among military veterans
One day, while Dr Ross O’Neill, chief executive of Neuromod, the Irish medtech firm, was cleaning in his house, he noticed that the high-suction mode of his vacuum was oppressively loud. He decided to hold his phone’s decibel reader up to the device, and its leonine roar to see how loud it truly was; the reading came in at 85 decibels.
According to noise comparisons compiled by the University of Purdue, this...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
PM Group reports 30% profits increase and announces 200 new jobs in Ireland
The project delivery firm said that pharmaceutical projects accounted for almost two-thirds of its overall revenue for 2020, which rose to almost €400 million
Neuromod Devices to double Irish headcount within next year
The medtech company, which specialises in neuromodulation devices indicated for the treatment of tinnitus, said it hopes to roll out its product in European countries such as France, Spain and the Netherlands
Malin shareholders in line for windfall after €119 million cash boost
Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year